Sanofi-Aventis’ Insulin Pen Prone To Medication Errors – ISMP
This article was originally published in The Pink Sheet Daily
OptiClik insulin delivery system’s digital display, when incorrectly oriented, may cause overdosing or subtherapeutic dosing, according to Medication Safety Alert.
You may also be interested in...
The Institute of Medicine report on medication errors also recommends FDA issue guidances this year on packaging and drug naming.
The OptiClick reusable “pen” injection system will be used with insulin products Lantus, Apidra; both had been approved for subcutaneous injection. Aventis has not announced its launch plans for OptiClick.
Adiana uses a polymer matrix insert to block the fallopian tubes instead of a metal coil, offering a benefit over Essure, which carries a perforation risk on implantation, Hologic exec says.